Trending Stocks Of Drug Manufacturers Major – Bristol Myers Squibb Co. (NYSE:BMY), A.P. Pharma, Inc. (OTC:APPA)
New York, NY – (Net PR News) – 03/27/2013–smartOTCis the premiere destination for Investors and novices alike who wish to receive information on fast moving OTC stocks and undiscovered companies. Most of these companies are considered penny stocks and trade on the Pink Sheet or OTC BB market. Our daily alerts help investors cut their research time in half as we send out small cap and penny stock alerts that are displaying signs of a potential rally.
Sign up For Our No. 1 Rated Stock Newsletter to make Huge Profitshttp://www.smartotc.com
SmartOTC brings a special trend analysis of these stocks: Bristol Myers Squibb Co. (NYSE:BMY), A.P. Pharma, Inc. (OTC:APPA)
Trend analysis report of stocks, Drug Manufacturers Major industry of the Healthcare sector. Bristol Myers Squibb Co. (NYSE:BMY) remained a high volume stock in its industry and A.P. Pharma, Inc.(OTC:APPA) remained in the news during the last trading session due to their latest news and sizzling activities.
Bristol Myers Squibb Co. (NYSE:BMY) reported that its Board of Directors has announced a quarterly dividend of thirty-five cents ($0.35) per share on the $0.10 par value common stock of Bristol Myers Squibb. It will be payable on 1st May, 2013, to stockholders of record on 5th April, 2013.
Drug Manufacturers Major company showing bullish momentum during prior trade, Bristol Myers Squibb Co. (NYSE:BMY) closed at the price of $40.68 by scoring +1.04%. The 52 week range of BMY was $30.64 – $40.74.
Is BMY a Solid Investment at These Levels? Read This Report For Details
BMY’s stocks traded with total volume of 6,779,100 shares, while the average trading remained 9.62 million shares.
Previous 5 days graph demonstrated a positive move of 4.41%. BMY’s quarterly performance remained in the green with the percentage of 26.57, while its year to date performance showed that the stock plunged overall 24.82%.
A.P. Pharma, Inc. (OTC:APPA) declared its net loss remained $7.7 million, or $0.03 per share, for the 4th Q of 2012, in comparison to the year ago 4th Q of $4.3 million, or $0.02 per share.
APPA’s net loss reported $23.3 million, or $0.10 per share, for the 2012, versus the prior year of $11.8 million, or $0.10 per share.
Where APPA is Headed Exactly? Find out in This Trend Analysis Reports
Healthcare Sector Company moving down during the previous trading session, A.P. Pharma, Inc. (OTC:APPA) traded with a plunge of -3.17% and closed at $0.609 after gaining total volume of 4,760,600 shares.
APPA has total market capitalization of $184.04 billion with a total of 302.21 million outstanding shares.
If we look at the previous six month’s performance of the stock, it remained gaining with the rise of 4.1%. In its last one month’s trade it jumped -15.28%. A.P. Pharma’s earnings per share is $-0.09, while its beta value stands at 0.70 points.
smartOTC is the premiere destination for Investors and novice alike who wish to receive information on fast moving OTC penny stocks and undiscovered companies. We are a marketing firm that releases paid reports on undiscovered companies looking to tell their stories. Most of these companies are considered penny stocks and trade on the Pink Sheet or OTC BB market. Our daily alerts help investors cut their research time in half as we send out small cap and penny stock alerts that are displaying signs of a potential rally.
While penny stocks pose a much more significant risk factor compared to large cap stocks, their lure of quick gains makes it a trading choice for many small time and beginner investors. There is nothing wrong with investments into penny stocks, the best advice is to do your own research and consult with your own financial professional. smartOTC reports and alerts should only be used as a starting point for your own due diligence.
PLEASE NOTE WELL: This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Smartotc.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The disclaimer is to be read and fully understood before using our site, or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.
Read Our Full Disclaimer at http://www.smartotc.com/disclaimer